|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 565.09 USD | +1.34% |
|
+7.21% | +0.61% |
| 06-17 | Medpace: At the Heart of the Small-Cap Biopharma Crisis |  |
| 06-05 | PriorNilsson Evolve Global rose 3.64 percent in May - trimmed positions in Beijer Alma and OEM | FW |
| Market Cap | 15.92B 13.92B 12.82B 11.89B 22.62B 1,519B 22.89B 153B 59.62B 745B 59.8B 58.49B 2,581B | P/E 2026 * |
33.2x | P/E 2027 * | 30.4x |
|---|---|---|---|---|---|
| Enterprise Value | 14.76B 12.89B 11.88B 11.02B 20.96B 1,407B 21.21B 142B 55.25B 691B 55.41B 54.2B 2,391B | EV / Sales 2026 * |
5.32x | EV / Sales 2027 * | 4.85x |
| Free-Float |
80.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | +1.34% | ||
| 1 week | +7.21% | ||
| Current month | +6.70% | ||
| 1 month | +24.40% | ||
| 3 months | +13.39% | ||
| 6 months | -3.70% | ||
| Current year | +0.61% |
| 1 week | 523.69 |  | 567.91 |
| 1 month | 445 | | 567.91 |
| Current year | 373 | | 628.92 |
| 1 year | 306.7 | | 628.92 |
| 3 years | 227.21 | | 628.92 |
| 5 years | 126.94 | | 628.92 |
| 10 years | 21.76 | | 628.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 69 | 1992-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 51 | 2021-07-31 |
Reinilde Heyrman
CTO | Chief Tech/Sci/R&D Officer | 65 | 2017-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 69 | 1992-06-30 |
Robert Kraft
BRD | Director/Board Member | 55 | 2016-06-30 |
Brian Carley
BRD | Director/Board Member | 72 | 2016-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Fiscal year | Director | 56 | 0.0002% | ||
| 06-29 | Fiscal year | Director | 72 | 0.0003% | ||
| 06-29 | Fiscal year | Director | 66 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.34% | +7.21% | +75.77% | +138.54% | 15.92B | |
| +1.08% | +8.57% | +3.61% | +9.34% | 49.92B | |
| +0.40% | +4.34% | +401.69% | +606.81% | 40.23B | |
| -0.52% | +7.76% | +25.41% | -6.76% | 34.55B | |
| +3.97% | +10.56% | +26.06% | +61.61% | 33.09B | |
| -4.19% | +6.03% | +3.76% | +32.17% | 27.51B | |
| -2.40% | +2.75% | - | - | 17.05B | |
| -0.95% | -0.38% | +12.92% | +17.96% | 13.86B | |
| +1.69% | +2.46% | +93.44% | +97.16% | 13.52B | |
| -4.52% | +52.54% | +1,733.57% | +733.76% | 13.31B | |
| Average | -0.41% | +11.12% | +264.02% | +187.84% | 25.9B | |
| Weighted average by Cap. | -0.01% | +9.17% | +181.50% | +169.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.77B 2.42B 2.23B 2.07B 3.94B 265B 3.99B 26.65B 10.39B 130B 10.42B 10.19B 450B | 2.95B 2.58B 2.37B 2.2B 4.19B 281B 4.24B 28.31B 11.03B 138B 11.07B 10.82B 478B |
| Net income | 492M 430M 396M 368M 699M 46.96B 708M 4.73B 1.84B 23.04B 1.85B 1.81B 79.79B | 539M 471M 434M 403M 766M 51.43B 775M 5.18B 2.02B 25.24B 2.02B 1.98B 87.39B |
| Net Debt | -1.17B -1.02B -941M -873M -1.66B -111B -1.68B -11.23B -4.38B -54.71B -4.39B -4.29B -189B | -1.62B -1.41B -1.3B -1.21B -2.3B -154B -2.33B -15.54B -6.06B -75.72B -6.07B -5.94B -262B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | US$565.09 | +1.34% | 234,156 |
| 26-07-02 | US$557.60 | +2.58% | 356,575 |
| 26-07-01 | US$543.57 | +2.64% | 312,635 |
| 26-06-30 | US$529.59 | -0.96% | 335,554 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
